Detalles de la búsqueda
1.
A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol.
Br J Clin Pharmacol
; 89(6): 1809-1819, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36562925
2.
Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitus.
Diabetes Obes Metab
; 20(9): 2274-2281, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29770541
3.
ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.
Am J Hum Genet
; 93(5): 900-5, 2013 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24119685
4.
Pharmacokinetics of teriparatide after subcutaneous administration to volunteers with renal failure: a pilot study.
Int J Clin Pharmacol Ther
; 52(2): 166-74, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24361089
5.
[(6)Development of Translational Research and Clinical Research Support Systems in Academia].
No Shinkei Geka
; 47(7): 805-813, 2019 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-31358701
6.
Causality Assessment Between Drugs and Fatal Cerebral Haemorrhage Using Electronic Medical Records: Comparative Evaluation of Disease-Specific and Conventional Methods.
Drugs Real World Outcomes
; 11(2): 221-229, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321346
7.
Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease.
Ann Clin Transl Neurol
; 10(2): 237-245, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36547017
8.
Antiviral effect and safety of nafamostat mesilate in patients with mild early-onset COVID-19: An exploratory multicentre randomized controlled clinical trial.
Int J Antimicrob Agents
; 62(3): 106922, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429450
9.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.
Int J Infect Dis
; 128: 355-363, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610659
10.
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.
EClinicalMedicine
; 59: 101920, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256098
11.
Effect of renal impairment on the pharmacokinetics of memantine.
J Pharmacol Sci
; 119(4): 324-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22863669
12.
Zonisamide attenuates MPTP neurotoxicity in marmosets.
J Pharmacol Sci
; 114(3): 298-303, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20948167
13.
Inter- and intra-individual variation in L-dopa pharmacokinetics in the treatment of Parkinson's disease.
Parkinsonism Relat Disord
; 15 Suppl 1: S21-4, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19131037
14.
Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immunodeficiency virus.
Neuropathology
; 29(1): 13-9, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18507770
15.
A Novel Method to Estimate Long-Term Chronological Changes From Fragmented Observations in Disease Progression.
Clin Pharmacol Ther
; 105(2): 436-447, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29951994
16.
Ethnic differences in fat and muscle mass and their implication for interpretation of bioelectrical impedance vector analysis.
Appl Physiol Nutr Metab
; 44(6): 619-626, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30354265
17.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 2. Dementia].
Nihon Naika Gakkai Zasshi
; 102(8): 1916-22, 2013 Aug 10.
Artículo
en Japonés
| MEDLINE | ID: mdl-24167848
18.
Notable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19.
J Clin Pharmacol
; 57(11): 1491-1499, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679023
19.
[Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease].
Rinsho Shinkeigaku
; 45(11): 895-8, 2005 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-16447756
20.
Accelerating Regulatory Science Initiatives for the Development of Drugs for Alzheimer's Disease in Japan.
Clin Ther
; 37(8): 1622-6, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26342202